USANA announced its Board of Directors has formed a Sustainability Committee, with the purpose of overseeing and advising on matters related to corporate sustainability, including environmental, social and governance (ESG) and corporate social responsibility (CSR). This new committee will ensure USANA remains accountable and aligned with sustainability, ESG and CSR in its business strategies and…

Read More
appointment

USANA Health Sciences, Inc. announced its year-end and fiscal fourth quarter financial results. Fourth quarter net sales totaled $310.5 million, an increase of 14.5% year-over-year, while fiscal year net sales increased 7% year-over-year to $1.135 billion. The fourth quarter diluted EPS increased 32.6% year-over-year, resulting in a record $1.87, while fiscal year diluted EPS increased…

Read More
Code of Ethics

USANA Health Sciences, Inc. announced third quarter 2020 net sales increased 14.5 percent year-over-year to $298.5 million. According to the company, the increase was due to strong product demand and successful incentive programs. For the quarter, active customers increased 16.5 percent year-over-year to a record 650,000. Regionally, net sales in the Asia Pacific region was…

Read More

USANA Health Sciences, Inc. announced the appointment of John T. Fleming to the company’s board of directors effective September 4, 2020. “I’m very pleased to welcome John Fleming to USANA’s board of directors,” said Kevin Guest, USANA’s CEO and chairman of the Board. “John is a veteran direct selling industry leader, writer, executive and consultant.…

Read More
Code of Ethics

USANA Health Sciences, Inc. (NYSE: USNA) yesterday announced financial results for its fiscal second quarter ended June 27, 2020. According to the company, continued strong demand and successful promotions combined to generate $259.0 million in net sales, up 1.2 percent versus prior-year quarter. Active customers totaled 599,000, an increase of 7.9 percent versus the prior-year…

Read More

USANA Health Sciences, Inc. announced $266.6 million in net sales for first quarter ended March 28, 2020, down 2.3 percent versus the prior-year quarter. “During this unprecedented period, we extend our gratitude to medical personnel, health officials, government leaders and volunteers around the world who are working tirelessly to respond to the COVID-19 pandemic,” said…

Read More
USANA Home Office

USANA Health Sciences, Inc. (NYSE: USNA) yesterday announced financial results for its fiscal fourth quarter and full year ended December 28, 2019. Fourth quarter 2019 net sales were $271.3 million, compared with $299.0 million in the prior-year period. The company’s total number of active Customers at the end of the fourth quarter was 586,000, compared…

Read More
USANA Q3

USANA Health Sciences, Inc. (NYSE: USNA) announced financial results for its fiscal third quarter ended September 28, 2019. Third quarter 2019 net sales were $260.6 million, compared with $296.8 million in the prior-year period, or a 12.2 percent decrease year-over-year. The company’s total number of active Customers at the end of the third quarter was…

Read More

Public Direct Sellers: Why We Have “Regulatory” and “China” as Risk Factors; Stocks Feeling the Pain China deteriorates substantially, and it’s not geopolitics  Business in China for the publicly traded Direct Selling stocks slowed substantially in the Q2 due to the government’s crackdown on direct selling nutrition companies earlier in the year. The most exposed…

Read More